The Corporate Advisory Team
PharmaVentures' Corporate Advisory team has a broad range of experiences covering multiple sectors of the pharmaceutical and biotechnology industries.
Fintan Walton (CEO And Founder)
Dr Walton is the Founder and CEO of PharmaVentures. He was educated at the University of Michigan (US) and Trinity College (Dublin, Ireland), and subsequently he gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992). As an entrepreneur, Dr Walton co-founded CONNECT Pharma in 1992, a company focused on assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making including strategic alliances, Mergers & Acquisitions and equity financing. In 1997 the company became PharmaVentures. His company has worked with blue chip clients on a global basis, delivering more than 500 assignments for companies in 37 countries. Clients have included major pharmaceutical and biotechnology companies as well as diversified chemical corporations, medical device, generic and OTC companies. His clients have included major banks, investment/merchant banks, and private equity and venture capital groups. Although Dr Walton’s main focus is his role as Chief Executive Officer of PharmaVentures, he is available for some consultancy assignments.
Kevin Bottomley, BSc. (Hons) (Head of Transactions)
Kevin is an experienced business development specialist, with over 25 years of experience in pharmaceutical and biotechnology companies involving senior positions in research, alliance management and business development. He has a proven track record of successful deal-making having worked at Roche, Quintiles, Hoechst (Sanofi-Aventis) and at Inpharmatica, where from 2001 to 2006 he was a Senior Director of Business Development. Kevin has a degree in Pharmacology from Kings College, University of London.
Watch Kevin on PharmaTelevision
Adrian Dawkes, PhD (Senior Director)
Adrian has significant multi-discipline expertise spanning research & development through to sales, marketing and business development from 25 years in the pharmaceutical, biotechnology and in vitro diagnostics sectors. Adrian has held senior positions with Johnson & Johnson, drug discovery platform company Acumen Bioscience and the Healthcare Consultancy company Execute Technologies. Adrian has a BSc in Biochemistry and a PhD in Immunochemistry from Oxford Brookes.
Watch Adrian on PharmaTelevision
Kate Moore, PhD (Director)
Kate has 15 years of experience in the biotechnology industry, most recently as Director of Business Development at TopoTarget. Kate has a successful track record in negotiating in- and out- licensing deals, conducting market evaluations and technical and commercial due diligence. Kate has also held positions in marketing and research at BD Biosciences, BioCarta and Prolifix. Kate has an undergraduate degree from Oxford University and a PhD in Molecular Biology from University College London.
Watch Kate on PharmaTelevision